CALR and essential thrombocythemia: Using exome sequencing, calreticulin (CALR) frameshift mutations were discovered in myeloproliferative neoplasms (MPN) and shown to be restricted to essential thrombocythemia (ET) and primary myelofibrosis (PMF) [1, 2].